Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and Vasopressin in Moral Decision Making
NCT04890470Completed
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Mar 2021
- Primary completion
- Dec 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin nasal spray and vasopressin (3 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoint: Behavioral index of moral decision task at 105 months. Started Mar 2021; status: completed.
02
Drugs
oxytocin nasal sprayvasopressin
Beyond the preview
Go deeper on NCT04890470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04890470.